Rapid disease progression in a patient with mismatch repair-deficient and cortisol secreting adrenocortical carcinoma treated with pembrolizumab

CONTEXT: Metastatic adrenocortical carcinoma (ACC) is an aggressive malignancy with a poor prognosis and limited therapeutic options. A subset of ACC is due to Lynch syndrome, an inherited tumor syndrome resulting from germline mutations in mismatch repair (MMR) genes. It has been demonstrated that...

Descripción completa

Detalles Bibliográficos
Autores principales: Casey, R.T., Giger, O., Seetho, I., Marker, A., Pitfield, D., Boyle, L.H., Gurnell, M., Shaw, A., Tischkowitz, M., Maher, E.R., Chatterjee, V.K., Janowitz, T., Mells, G., Corrie, P., Challis, B.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: W.B. Saunders 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286406/
https://www.ncbi.nlm.nih.gov/pubmed/30262398
http://dx.doi.org/10.1053/j.seminoncol.2018.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286406/
https://www.ncbi.nlm.nih.gov/pubmed/30262398
http://dx.doi.org/10.1053/j.seminoncol.2018.06.001

Ejemplares similares